ATE375350T1 - Modulatoren von peroxisome proliferator- aktivierten rezeptoren - Google Patents
Modulatoren von peroxisome proliferator- aktivierten rezeptorenInfo
- Publication number
- ATE375350T1 ATE375350T1 AT03706045T AT03706045T ATE375350T1 AT E375350 T1 ATE375350 T1 AT E375350T1 AT 03706045 T AT03706045 T AT 03706045T AT 03706045 T AT03706045 T AT 03706045T AT E375350 T1 ATE375350 T1 AT E375350T1
- Authority
- AT
- Austria
- Prior art keywords
- modulators
- peroxisome proliferator
- activated receptors
- aliphatic linker
- acylsulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35942802P | 2002-02-21 | 2002-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE375350T1 true ATE375350T1 (de) | 2007-10-15 |
Family
ID=27766083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03706045T ATE375350T1 (de) | 2002-02-21 | 2003-02-07 | Modulatoren von peroxisome proliferator- aktivierten rezeptoren |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050250831A1 (de) |
EP (1) | EP1490058B1 (de) |
JP (1) | JP2005523292A (de) |
AT (1) | ATE375350T1 (de) |
AU (1) | AU2003207808A1 (de) |
DE (1) | DE60316780T2 (de) |
ES (1) | ES2292937T3 (de) |
WO (1) | WO2003072099A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004010889T2 (de) | 2003-02-14 | 2008-12-11 | Eli Lilly And Co., Indianapolis | Sulfonamid-derivate als ppar-modulatoren |
US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
US8187727B2 (en) * | 2005-07-22 | 2012-05-29 | Lg Chem, Ltd. | Imidazole derivatives, preparation method thereof and organic electronic device using the same |
WO2008126732A1 (ja) * | 2007-04-05 | 2008-10-23 | Daiichi Sankyo Company, Limited | 縮合二環式ヘテロアリール誘導体 |
EP2404918B1 (de) | 2009-03-05 | 2016-11-30 | Daiichi Sankyo Company, Limited | Pyridinderivat als ppary inhibitor |
GB201617630D0 (en) | 2016-10-18 | 2016-11-30 | Cellcentric Ltd | Pharmaceutical compounds |
GB201806320D0 (en) | 2018-04-18 | 2018-05-30 | Cellcentric Ltd | Process |
CR20220316A (es) | 2019-12-06 | 2022-10-07 | Vertex Pharma | Tetrahidrofuranos sustituidos como moduladores de canales de sodio |
WO2021169769A1 (zh) * | 2020-02-28 | 2021-09-02 | 四川科伦博泰生物医药股份有限公司 | 芳香族化合物及其药物组合物和用途 |
CN117794920A (zh) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2641060A1 (de) * | 1976-09-11 | 1978-03-16 | Hoechst Ag | Beta-lactamverbindungen und verfahren zu ihrer herstellung |
DE2907089A1 (de) * | 1979-02-23 | 1980-09-04 | Hoechst Ag | Herbizide mittel |
NZ193011A (en) * | 1979-03-19 | 1983-03-15 | Ici Australia Ltd | Diarylamine derivatives intermediates herbicidal compositions |
DE3561461D1 (en) * | 1984-03-14 | 1988-02-25 | Cassella Farbwerke Mainkur Ag | Process for the production of benzimidazolyl, benzoxazolyl and benzothiazolyl oxyphenoxypropionate derivatives |
FR2766822B1 (fr) * | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1208323C (zh) * | 1999-04-06 | 2005-06-29 | 三共株式会社 | α-取代羧酸衍生物 |
ES2287016T3 (es) * | 1999-04-28 | 2007-12-16 | Sanofi-Aventis Deutschland Gmbh | Derivados de diaril-acido como ligandos del receptor ppar. |
FR2829765A1 (fr) * | 2001-09-14 | 2003-03-21 | Lipha | Derives imidazolylalkoxylarylalcanoiques leurs applications en therapeutique |
-
2003
- 2003-02-07 EP EP03706045A patent/EP1490058B1/de not_active Expired - Lifetime
- 2003-02-07 WO PCT/US2003/003112 patent/WO2003072099A1/en active IP Right Grant
- 2003-02-07 ES ES03706045T patent/ES2292937T3/es not_active Expired - Lifetime
- 2003-02-07 JP JP2003570845A patent/JP2005523292A/ja active Pending
- 2003-02-07 AU AU2003207808A patent/AU2003207808A1/en not_active Abandoned
- 2003-02-07 DE DE60316780T patent/DE60316780T2/de not_active Expired - Fee Related
- 2003-02-07 AT AT03706045T patent/ATE375350T1/de not_active IP Right Cessation
- 2003-02-07 US US10/502,696 patent/US20050250831A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005523292A (ja) | 2005-08-04 |
DE60316780D1 (de) | 2007-11-22 |
WO2003072099A1 (en) | 2003-09-04 |
DE60316780T2 (de) | 2008-07-24 |
EP1490058B1 (de) | 2007-10-10 |
AU2003207808A1 (en) | 2003-09-09 |
US20050250831A1 (en) | 2005-11-10 |
EP1490058A1 (de) | 2004-12-29 |
ES2292937T3 (es) | 2008-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE415160T1 (de) | Modulatoren von peroxisome proliferator- aktivierten rezeptoren | |
ME00411B (me) | Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma | |
ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
ATE434616T1 (de) | Aktivator des peroxisomproliferator-aktivierten rezeptors delta | |
DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
ATE297203T1 (de) | Antithrombotische mitteln | |
RS50537B (sr) | Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii | |
HRP20080022T3 (en) | Pyrrolopyridine derivatives and their use as crth2 antagonists | |
CY1107388T1 (el) | Αγωνιστες αλφα υποδοχεα ενεργοποιουμενου απο πολλαπλασιαστες υπεροξυσωματων | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
ATE283253T1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ | |
EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
ATE375350T1 (de) | Modulatoren von peroxisome proliferator- aktivierten rezeptoren | |
DK0605228T3 (da) | Thiazolidindionderivater, deres fremstilling og anvendelse | |
RS52881B (en) | BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS | |
TR200402069T4 (tr) | Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması | |
DE69507293T2 (de) | Benzamid-derivate als vasopressin-antagonisten | |
ATE261941T1 (de) | Heterocyclische amide als inhibitoren von faktor xa | |
WO2003048130A3 (en) | Peroxisome proliferator activated receptor agonists | |
EE200300515A (et) | Arüülsulfoonamiidid kui viirusevastased ained | |
UA89940C2 (en) | 3-phenylpropionic acid derivatives | |
TW200635911A (en) | Sulfanyl substituted phenyl methanones | |
ATE348800T1 (de) | 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |